跳至主要内容
临床试验/NCT03339791
NCT03339791已完成不适用

Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass for Treatment of Severe Obesity in Patients With 65 Years or Older: a Randomized Controlled Trial - The "BaSE" Trial - Bariatric Surgery in the Elderly.

University of Sao Paulo General Hospital2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2017年9月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
36
试验地点
2
主要终点
Surgical Complications

研究概览

简要总结

The aim of the study is to compare two different bariatric procedures performed in patients with 65 years or more: gastric bypass and sleeve gastrectomy. Primary outcomes will be weight loss, control of comorbidities and morbidity of the operation. Secondary outcomes are related to functionality, that will be evaluated with specific tests.

详细描述

Introduction

Surgical treatment of obesity in patients over 65 years of age is controversial. For patients in this age group, there is a prevailing concept that the risk / benefit ratio of the procedure should be evaluated for each individual patient, without determining objective criteria or outcomes that characterize this benefit. Increased surgical risk in patients older than 65 years is undoubtedly a limiting factor for the broader indication of bariatric surgery in this population. The two most applied surgical techniques are Sleeve Gastrectomy and Roux-en-Y Gastric Bypass. Most of the studies that evaluated the two techniques in elderly patients are retrospective, prospective non-randomized, or contemplated only one technique. Recent, studies concluded that in the elderly the weight loss with Gastric Bypass was higher, but the surgical morbidity with the Sleeve was lower and there was no difference in the resolution of comorbidities between the two techniques. In evaluating the benefits of surgery, most studies address outcomes such as weight loss and control of metabolic and cardiovascular comorbidities. Outcomes that are specific to the treatment of obesity in the elderly, such as improvement of functionality, decreased fragility and improvement of the quality of life have not been studied yet. In this field, there is concern that excessive weight loss, accompanied by loss of muscle mass may compromise the mentioned parameters, especially in individuals who already have loss of bone and muscle mass before surgery. For this reason, the assessment of bone mass and body composition in the preoperative period of these individuals is fundamental. In order to identify the benefits of weight loss promoted by surgery and life expectancy, the elderly patients in preparation for operation at the Bariatric Surgery Unit of the Hospital das Clinicas University of São Paulo School of Medicine are submitted to a geriatric evaluation, which includes the analysis of their functional dependency profile, Important prognostic factor in this population. Objectives: The primary objective of the study will be to evaluate surgical morbidity and short-term (weight loss, comorbid control) outcomes of surgical treatment of obesity in patients over 65 years of age, comparing two techniques: Sleeve Gastrectomy (SG) and Gastric Bypass (GB). The secondary objective will be to evaluate the body composition of the individuals, before and after the surgery, comparing the two techniques. Patients and methods: This is a prospective study, in which 40 consecutive patients, aged 65 years and over, will be admitted to the Bariatric and Metabolic Surgery Unit of the Discipline of Digestive System Surgery of Hospital das Clinicas University of São Paulo School of Medicine with indication criteria for bariatric surgery. Patients will be randomized into two groups according to the surgical technique to be used: SG or GB. Data related to surgical morbidity, weight loss, control of comorbidities, nutritional deficiencies, changes in body composition and functionality will be evaluated and compared after a follow-up of at least 12 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
65 Years 至 80 Years(Older Adult)
性别
All
接受健康志愿者

入选标准

  • BMI over 40 Kg/m2 for at least 5 years with failure of obesity medical treatments
  • BMI over 35 Kg/m2 with at least 2 comorbidities and failure of medical treatments

排除标准

  • prior bariatric surgery
  • clinical or psychological conditions that contraindicate bariatric surgery

结局指标

主要结局

Surgical Complications

时间窗: 30 days

Bleeding, Leakage, Fistula, Bowel obstruction

Mortality

时间窗: 90 days

mortality

Improvement of Type II diabetes

时间窗: baseline and 1 year

Measure of glycated hemoglobin

Improvement of LDL

时间窗: baseline and 1 year

measure of LDL

Clinical complications

时间窗: 30 days

cardiac, pulmonary, other

Excess weight loss

时间窗: 1 year

excess weight loss (%EWL); considering the normal weight the equivalent to the BMI 25 Kg/m2

Improvement of hypertension

时间窗: baseline and 1 year

measure of blood pressure (mmHg)

Improvement of hypertension by use of medication

时间窗: baseline and 1 year

evaluation of the number of drugs used to treat hypertension

Improvement of HDL

时间窗: baseline and 1 year

measure of HDL

Improvement of triglycerides

时间窗: baseline and 1 year

measure of triglycerides

Total Weight loss

时间窗: 1 year

Weight loss measured in percentage of weight loss (%WL)

次要结局

  • Body composition(baseline and 1 year)
  • Functionality(baseline and 1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Denis Pajecki

Principal Investigator

University of Sao Paulo General Hospital

研究点 (2)

Loading locations...

相似试验